Biohaven ROE 2016-2023 | BHVN
Current and historical return on equity (ROE) values for Biohaven (BHVN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Biohaven ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-03-31 |
$-0.54B |
$0.47B |
-712.13% |
| 2022-12-31 |
$-0.57B |
$0.54B |
360.19% |
| 2022-09-30 |
$-0.29B |
$0.10B |
102.37% |
| 2022-06-30 |
$-0.28B |
$-0.81B |
60.39% |
| 2022-03-31 |
$-0.05B |
$-0.47B |
12.44% |
| 2021-12-31 |
$-0.21B |
$0.04B |
66.31% |
| 2021-09-30 |
$-0.10B |
$-0.59B |
23.28% |
| 2021-06-30 |
$-0.24B |
$-0.46B |
71.89% |
| 2021-03-31 |
$-0.21B |
$-0.28B |
91.84% |
| 2020-12-31 |
$-0.12B |
$-0.39B |
91.71% |
| 2020-09-30 |
$-0.70B |
$-0.21B |
2198.43% |
| 2020-06-30 |
$-0.61B |
$-0.04B |
-1182.52% |
| 2020-03-31 |
$-0.64B |
$0.12B |
-597.20% |
| 2019-12-31 |
$-0.53B |
|
-524.07% |
| 2019-09-30 |
$-0.43B |
$0.12B |
-313.36% |
| 2019-06-30 |
$-0.39B |
$0.19B |
-310.58% |
| 2019-03-31 |
$-0.22B |
$0.10B |
-200.46% |
| 2018-12-31 |
$-0.24B |
$0.15B |
-216.22% |
| 2018-09-30 |
$-0.21B |
$0.07B |
-199.53% |
| 2018-06-30 |
$-0.19B |
$0.12B |
-150.68% |
| 2018-03-31 |
$-0.20B |
$0.11B |
-136.50% |
| 2017-12-31 |
$-0.14B |
$0.13B |
-110.98% |
| 2017-09-30 |
$-0.14B |
$0.16B |
-150.41% |
| 2017-06-30 |
$-0.12B |
$0.19B |
-233.18% |
| 2017-03-31 |
$-0.08B |
$0.02B |
-1866.67% |
| 2016-12-31 |
$-0.06B |
$-0.00B |
12800.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.059B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
